Sudden Cardiac Death and Arrhythmias.
暂无分享,去创建一个
[1] R. Hauer,et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.
[2] G. Kay,et al. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. , 2004, Journal of the American College of Cardiology.
[3] S. Priori,et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.
[4] K. Reinier,et al. Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.
[5] N. Boyle,et al. Catheter ablation of ventricular tachycardia. , 2010, Circulation.
[6] A. Skanes,et al. How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia , 2011, Circulation. Arrhythmia and electrophysiology.
[7] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.
[8] M. Rosenqvist,et al. Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest. , 2015, The New England journal of medicine.
[9] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[10] N. Estes,et al. Predicting and preventing sudden cardiac death. , 2011, Circulation.
[11] A. Castellanos,et al. Indications for implantable cardioverter-defibrillators based on evidence and judgment. , 2009, Journal of the American College of Cardiology.
[12] S. Petersen,et al. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging , 2017, Circulation. Cardiovascular imaging.
[13] A. Skanes,et al. Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome , 2010, Circulation. Arrhythmia and electrophysiology.
[14] Thomas D Rea,et al. Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. , 2010, Circulation.
[15] J. Healey,et al. Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry , 2016, Circulation. Arrhythmia and electrophysiology.
[16] A. Skanes,et al. Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? , 2010, Heart rhythm.
[17] Timothy C. Y. Chan,et al. Optimizing a Drone Network to Deliver Automated External Defibrillators , 2017, Circulation.
[18] P. Kudenchuk,et al. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. , 1990, Journal of the American College of Cardiology.
[19] A. Krahn,et al. Experience with bisoprolol in long-QT1 and long-QT2 syndrome , 2016, Journal of Interventional Cardiac Electrophysiology.
[20] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[21] A. Wilde,et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. , 2010, Journal of the American College of Cardiology.
[22] S. Russell,et al. Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.
[23] J. Healey,et al. Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) , 2009, Circulation.
[24] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[25] P. Schwartz,et al. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. , 2010, Heart rhythm.
[26] R. Redon,et al. Clinical Yield of Familial Screening After Sudden Death in Young Subjects: The French Experience , 2017, Circulation. Arrhythmia and electrophysiology.
[27] T. Aufderheide,et al. Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest. , 2017, Journal of the American College of Cardiology.
[28] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[29] X. Jouven,et al. Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients Without ST-Segment Elevation Pattern: Insights From the PROCAT II Registry. , 2016, JACC. Cardiovascular interventions.
[30] A. Wilde,et al. Long-Term Outcome of Patients Initially Diagnosed With Idiopathic Ventricular Fibrillation: A Descriptive Study , 2016, Circulation. Arrhythmia and electrophysiology.
[31] O. Franco,et al. Declining incidence of sudden cardiac death from 1990-2010 in a general middle-aged and elderly population: The Rotterdam Study. , 2015, Heart rhythm.
[32] P. Kudenchuk,et al. Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests , 2018, Circulation.
[33] B. Gersh,et al. Sudden cardiac death: epidemiology and risk factors , 2010, Nature Reviews Cardiology.
[34] P. Lambiase,et al. Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[35] C. Tracy,et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.
[36] Riccardo Cappato,et al. Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest The Cardiac Arrest Study Hamburg (CASH) , 2000 .
[37] S. Szymkiewicz,et al. Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death , 2016, Circulation.
[38] S. Viskin,et al. Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome , 2004, Circulation.
[39] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[40] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[41] S. Priori,et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). , 2009, Heart rhythm.
[42] C. Deakin,et al. Public access defibrillation remains out of reach for most victims of out-of-hospital sudden cardiac arrest , 2014, Heart.
[43] K. Aonuma,et al. Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation. , 2012, Circulation. Arrhythmia and electrophysiology.
[44] S. Narayan,et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.
[45] M. Schalij,et al. High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival , 2014, Netherlands Heart Journal.
[46] S M Cobbe,et al. Surviving out of hospital cardiac arrest at home: a postcode lottery? , 2004, Emergency Medicine Journal.
[47] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[48] M Gent,et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.
[49] T. Kawamura,et al. Outcomes of Out‐of‐Hospital Cardiac Arrest by Public Location in the Public‐Access Defibrillation Era , 2014, Journal of the American Heart Association.
[50] Tachapong Ngarmukos,et al. Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.
[51] A. Moss,et al. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. , 2001, The American journal of cardiology.